Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Breast Neoplasms, Male 1 Advanced Breast Cancer 1

Interventions

exemestane 4 Tamoxifen 3 Paclitaxel 3 Letrozole 3 Goserelin 3 Cyclophosphamide 3 pegfilgrastim 2 Radiotherapy 2 Pyridoxine 2 Leuprolide 2 Fluorouracil 2 Epirubicin 2 Capecitabine 2 Bevacizumab 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 ribociclib 1 elacestrant 1 Zoledronic Acid 1 Trastuzumab 1 Taxes 1 Radiosurgery 1 Prochlorperazine 1 Palonosetron 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Neoadjuvant Therapy 1 Mometasone Furoate 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Neoplasms, Male × elacestrant × Clear all

NCT06492616 2026-05-27

ELEGANT

Stemline Therapeutics, Inc.

Phase 3 Recruiting

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡